Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,190.00
Bid: 12,210.00
Ask: 12,214.00
Change: 162.00 (1.35%)
Spread: 4.00 (0.033%)
Open: 12,036.00
High: 12,214.00
Low: 12,024.00
Prev. Close: 12,028.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: Liberum says buy Made.com; RBC cuts ConvaTec

Mon, 09th Aug 2021 09:42

(Alliance News) - The following London-listed shares received analyst recommendations on Monday morning and Friday:

----------

FTSE 100

----------

MORGAN STANLEY REINITIATES ASTRAZENECA WITH 'OVERWEIGHT' - PRICE TARGET 9,800 PENCE

----------

DEUTSCHE BANK RAISES LEGAL & GENERAL PRICE TARGET TO 325 (310) PENCE - 'BUY'

----------

DEUTSCHE BANK RAISES ROLLS-ROYCE PRICE TARGET TO 116 (113) PENCE - 'HOLD'

----------

JEFFERIES RAISES CRODA INTERNATIONAL PRICE TARGET TO 8,500 (7,100) PENCE - 'HOLD'

----------

JEFFERIES RAISES MONDI PRICE TARGET TO 2,300 (2,225) PENCE - 'BUY'

----------

JPMORGAN RAISES ASHTEAD GROUP PRICE TARGET TO 6,100 (5,050) PENCE - 'OVERWEIGHT'

----------

BARCLAYS RAISES TAYLOR WIMPEY PRICE TARGET TO 205 (195) PENCE - 'OVERWEIGHT'

----------

BARCLAYS CUTS OCADO PRICE TARGET TO 1,575 (1600) PENCE - 'UNDERWEIGHT'

----------

RBC CUTS HSBC PRICE TARGET TO 450 (480) PENCE - 'SECTOR PERFORM'

----------

JEFFERIES RAISES STANDARD CHARTERED PRICE TARGET TO 736 (610) PENCE - 'BUY'

----------

RBC CUTS HSBC PRICE TARGET TO 450 (480) PENCE - 'SECTOR PERFORM'

----------

GOLDMAN SACHS RAISES COMPASS GROUP PRICE TARGET TO 1,380 (1,350) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES LONDON STOCK EXCHANGE PRICE TARGET TO 8,890 (8,635) PENCE - 'OVERWEIGHT'

----------

CREDIT SUISSE RAISES LSE PRICE TARGET TO 8,800 (8,500) PENCE - 'OUTPERFORM'

----------

FTSE 250

----------

BERENBERG RAISES CAIRN ENERGY TO 'BUY' ('HOLD') - PRICE TARGET 235 (170) PENCE

----------

JPMORGAN RAISES TI FLUID SYSTEMS PRICE TARGET TO 350 (300) PENCE - 'NEUTRAL'

----------

BERENBERG RAISES DOMINO'S PIZZA PRICE TARGET TO 330 (300) PENCE - 'SELL'

----------

JPMORGAN CUTS FERREXPO PRICE TARGET TO 390 (400) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES LANCASHIRE PRICE TARGET TO 662 (613) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES HISCOX PRICE TARGET TO 1,155 (1,016) PENCE - 'OVERWEIGHT'

----------

RBC CUTS CONVATEC TO 'UNDERPERFORM' ('SECTOR PERFORM') - TARGET 213 (230) PENCE

----------

OTHER MAIN MARKET AND AIM

----------

LIBERUM INITIATES MADE.COM WITH 'BUY' - TARGET 250 PENCE

----------

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.